Submit Deal

ARQULE INC

Summary

ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 2.05 B

Avg. Deal Size£ 2.05 B

Market Context

Senior Management

Paolo Pucci
CEO
Brian Schwartz
Chief Medical Officer
Kathleen Farren

Sort

centerview partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 2.05 B

Total Value

skadden arps slate meagher & flom

HQ - New York

legal advisors (1)

1 Shared Deal

1 For

£ 2.05 B

Total Value

lifesci partners

HQ - New York

pr advisors (1)

1 Shared Deal

1 For

£ 2.05 B

Total Value

joele frank

HQ - New York

pr advisors (1)

1 Shared Deal

1 For

£ 2.05 B

Total Value

goodwin procter

HQ - Boston

legal advisors to financial advisors (1)

1 Shared Deal

1 For

£ 2.05 B

Total Value

bank of america

HQ - Charlotte

financial advisors (1)

1 Shared Deal

1 Opposite

£ 2.05 B

Total Value

covington & burling

HQ - Washington DC

legal advisors (1)

1 Shared Deal

1 Opposite

£ 2.05 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy